FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
The FDA late Friday started reversing termination notices for some employees that were laid off, informing workers to return ...
The top official in charge of food safety and nutrition at the Food and Drug Administration resigned this week, protesting ...
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
ZB Importing LLC has issued a recall for six varieties of Ülker snack rolls, biscuits and wafers due to undeclared wheat, ...
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
The shakes have also made at least 38 people ill, with 37 hospitalizations, the FDA said. The affected brands that sold the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback